Therapy News and Research

RSS

Continued rise of PSA value in prostate cancer patients can indicate relapsing disease

Prostate cancer patients who have a prostate-specific antigen (PSA) value of less than or equal to 1.5 at two years after external beam radiation therapy (EBRT) are less likely to have a cancer recurrence and cancer-related death, according to a study in the December 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

3 Dec 2009

Tripep receives approval to extend ChronVac-C study

Today Tripep (STO:TPEP) received the approval from the Swedish Medical Products Agency and the local ethical committee to give three patients in the highest dose group in the ChronVac-C® study one additional treatment with the therapeutic vaccine.

3 Dec 2009

Texas skilled nursing facilities acquired by Ensign Group

The Ensign Group, Inc., announced today that it has acquired three Texas skilled nursing facilities: the 93-bed Grand Terrace Rehabilitation & Healthcare Center in McAllen, the 100-bed Alta Vista Rehabilitation & Healthcare in Brownsville; and the 95-bed Veranda Rehabilitation & Healthcare in Harlingen. The acquisitions were effective December 1, 2009.

3 Dec 2009

PEG polymer may prevent GI injury during cancer radiotherapy

A non-absorbed, oral co-polymer therapy under development by Midway Pharmaceuticals demonstrated the ability to protect against damage to healthy gastrointestinal tissues and to prevent lethal bacterial infections in animal models of radiation damage.

3 Dec 2009

Videos can help overcome communication barriers and influence patients' choices for medical care

Patients with terminal brain cancer who watched a brief video illustrating options for end-of-life care were significantly more likely to indicate a preference for comfort measures only than were patients who listened to a verbal description of treatment choices.

3 Dec 2009

Study shows CIMT may be effective for treating hemiplegic cerebral palsy, but calls for more research

Constraint-induced movement therapy (CIMT) is a potentially effective form of intervention for children with hemiplegic cerebral palsy, but more research is needed, according to a new systematic review published in the November issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA).

3 Dec 2009

Medical research experts explore new strategies to speed up treatments for medical disorders

Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugural Partnering for Cures meeting.

3 Dec 2009

NIDA funds proposed 'seek and treat' strategy in the fight against HIV/AIDS

Dr. Julio Montaner - Director, British Columbia Centre for Excellence in HIV/AIDS (BC-CfE), and President, International AIDS Society - congratulated Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH), for taking a leadership role in the evaluation of the "Seek and Treat" strategy originally developed at the BC-CfE.

3 Dec 2009

Study: Stem cells from donor bone marrow may help repair heart damage

Adult stem cells may help repair heart tissue damaged by heart attack according to the findings of a new study to be published in the December 8 issue of the Journal of the American College of Cardiology. Results from the Phase I study show stem cells from donor bone marrow appear to help heart attack patients recover better by growing new blood vessels to bring more oxygen to the heart

3 Dec 2009

ImmunoCellular Therapeutics options immunotherapy targeting CSCs using abnormal Notch and Numb pathways

ImmunoCellular Therapeutics, Ltd., a biotechnology company that is focused on the development of novel immune-based cancer therapies, announced today that it has entered into an option agreement with The University of Texas M. D. Anderson Cancer Center relating to an immunotherapy targeting cancer stem cells (CSCs) which has demonstrated in pre-clinical animal models significant abilities to target and destroy CSCs.

3 Dec 2009

AstraZeneca and Targacept enter into agreement to develop and commercialize TC-5214

AstraZeneca and Targacept, Inc. today announced a collaboration and license agreement for the global development and commercialization of TC-5214, Targacept’s late-stage investigational product for major depressive disorder (MDD).

3 Dec 2009

More than 80 abstracts highlighting Bristol-Myers Squibb's oncology compound to be presented

Bristol-Myers Squibb Company today announced that more than 80 abstracts highlighting compounds from the company’s oncology portfolio will be presented at the 51st Annual Meeting of the American Society of Hematology (ASH) to be held December 5-8 in New Orleans.

3 Dec 2009

LSI collaborates with United Healthcare to meet the growing demand for spinal procedures

Laser Spine Institute (LSI), the leader in minimally invasive spinal surgery, is pleased to announce a partnership with United Healthcare and affiliates after an extensive six-month negotiation and clinical review process.

3 Dec 2009

CT imaging after chemotherapy with bevacizumab may help predict overall survival

Preliminary research suggests that criteria based on computed tomography (CT) imaging of changes in tumors from colorectal liver metastases after chemotherapy with the drug bevacizumab may have the potential to predict overall survival, according to a study in the December 2 issue of JAMA.

3 Dec 2009

Beta blockers and stress tests before non-cardiac surgeries should be avoided, according to study

Physicians should "throttle back" from routinely ordering stress tests and prescribing beta blockers to patients before non-cardiac surgeries, according to a report by the University of Michigan released online this week.

3 Dec 2009

Exercise remains one of the most effective interventions for peripheral artery disease

Peripheral artery disease (PAD) affects 5 million individuals in the U.S. and is the leading cause of limb amputations. Doctors have long considered exercise to be the single best therapy for PAD, and now a new study helps explain why. Led by researchers at Beth Israel Deaconess Medical Center and published in this week's Online Early Edition of the Proceedings of the National Academy of Sciences (PNAS), the findings demonstrate that a protein called PGC-1alpha plays a key role in the process.

3 Dec 2009

Guidelines to diagnose and manage complicated skin and soft tissue infections published

New evidence-based recommendations developed by the Surgical Infection Society to guide physicians in the diagnosis and management of complicated skin and soft tissue infections have been published in Surgical Infections, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com).

3 Dec 2009

Research finds change in the outlook of people with type 2 diabetes and heart disease

The outlook for individuals with type 2 diabetes and coronary artery disease is not as grim as originally believed, according to new Saint Louis University research published in Circulation, the Journal of the American Heart Association.

2 Dec 2009

Researchers discover ability of stem cells in brain cancer glioma to resist radiation therapy

Duke University Medical Center researchers have figured out how stem cells in the malignant brain cancer glioma may be better able to resist radiation therapy. And using a drug to block a particular signaling pathway in these cancer stem cells, they were able to kill many more glioma cells with radiation in a laboratory experiment.

2 Dec 2009

Adult stem cells may help repair heart tissue, reveals new study

2 Dec 2009

Therapy News and Research

Continued rise of PSA value in prostate cancer patients can indicate relapsing disease

Tripep receives approval to extend ChronVac-C study

Texas skilled nursing facilities acquired by Ensign Group

PEG polymer may prevent GI injury during cancer radiotherapy

Videos can help overcome communication barriers and influence patients' choices for medical care

Study shows CIMT may be effective for treating hemiplegic cerebral palsy, but calls for more research

Medical research experts explore new strategies to speed up treatments for medical disorders

NIDA funds proposed 'seek and treat' strategy in the fight against HIV/AIDS

Study: Stem cells from donor bone marrow may help repair heart damage

ImmunoCellular Therapeutics options immunotherapy targeting CSCs using abnormal Notch and Numb pathways

AstraZeneca and Targacept enter into agreement to develop and commercialize TC-5214

More than 80 abstracts highlighting Bristol-Myers Squibb's oncology compound to be presented

LSI collaborates with United Healthcare to meet the growing demand for spinal procedures

CT imaging after chemotherapy with bevacizumab may help predict overall survival

Beta blockers and stress tests before non-cardiac surgeries should be avoided, according to study

Exercise remains one of the most effective interventions for peripheral artery disease

Guidelines to diagnose and manage complicated skin and soft tissue infections published

Research finds change in the outlook of people with type 2 diabetes and heart disease

Researchers discover ability of stem cells in brain cancer glioma to resist radiation therapy

Adult stem cells may help repair heart tissue, reveals new study

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News